The clinical-stage biotech Genascence has closed a Series A financing led by Pacira BioSciences, generating $10.5 million. The funding round included investors Polymerase Capital, DeepWork Capital and University of Florida Research Foundation. The Palo Alto, California–based company is focused on treating musculoskeletal diseases with gene therapy. The company plans on using the funding for continued…